User profiles for Pierre Maheux
 | Pierre MaheuxUniversité de Sherbrooke Verified email at usherbrooke.ca Cited by 4703 |
[PDF][PDF] Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles
…, YDI Chen, J Jeppesen, P Maheux… - The Journal of …, 1993 - Am Soc Clin Investig
Subjects characterized by a predominance of small LDL particles (pattern B) have changes
in plasma triglyceride (TG) and HDL-cholesterol concentrations consistent with the presence …
in plasma triglyceride (TG) and HDL-cholesterol concentrations consistent with the presence …
[HTML][HTML] The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on …
Background The optimal source and amount of dietary carbohydrate for managing type 2
diabetes (T2DM) are unknown. Objective We aimed to compare the effects of altering the …
diabetes (T2DM) are unknown. Objective We aimed to compare the effects of altering the …
[HTML][HTML] Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label …
Introduction Whether long-term treatment with the twice-yearly, siRNA therapeutic inclisiran,
which reduces hepatic production of proprotein convertase subtilisin/kexin type 9 (PCSK9), …
which reduces hepatic production of proprotein convertase subtilisin/kexin type 9 (PCSK9), …
Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study
…, L Gönder-Frederick, P Maheux… - Clinical …, 2014 - Wiley Online Library
Objective To provide an update on glycaemic control in European patients with type 2
diabetes based on data from the nine‐country, cross‐sectional PANORAMA study ( NCT …
diabetes based on data from the nine‐country, cross‐sectional PANORAMA study ( NCT …
Evaluation of postural stability in elderly with diabetic neuropathy.
OBJECTIVE: The objective of this study was to compare clinical and biomechanical
characteristics of balance in diabetic polyneuropathic elderly patients and normal age-matched …
characteristics of balance in diabetic polyneuropathic elderly patients and normal age-matched …
Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
…, JL Chiasson, R Rabasa-Lhoret, P Maheux… - Diabetes …, 2000 - Am Diabetes Assoc
OBJECTIVE: To study the effect of acarbose, an alpha-glucosidase inhibitor, on insulin release
and insulin sensitivity in elderly patients with type 2 diabetes. RESEARCH DESIGN AND …
and insulin sensitivity in elderly patients with type 2 diabetes. RESEARCH DESIGN AND …
[PDF][PDF] Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content
…, G Bisson, CJ Mongeau, P Maheux - Journal of Nuclear …, 1998 - Soc Nuclear Med
… AndréCarpentier, Simon Jeannotte, Jean Verreault, Bernard Lefebvre, Guy Bisson,
Charles-Jacques Mongeau and Pierre Maheux … For correspondence or reprints contact …
Charles-Jacques Mongeau and Pierre Maheux … For correspondence or reprints contact …
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
…, JL Ardilouze, P Maheux… - American Journal …, 2007 - journals.physiology.org
The aim of this review is to explore the dysregulation of adrenocortical secretions as a major
contributor in the development of obesity and insulin resistance. Disturbance of adipose …
contributor in the development of obesity and insulin resistance. Disturbance of adipose …
Efficacy, safety, and tolerability of inclisiran in patients with homozygous familial hypercholesterolemia: results from the ORION-5 randomized clinical trial
BACKGROUND: Homozygous familial hypercholesterolemia is a genetic disease characterized
by extremely high levels of low-density lipoprotein cholesterol (LDL-C) and a high risk of …
by extremely high levels of low-density lipoprotein cholesterol (LDL-C) and a high risk of …
Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus
J Doucet, A Chacra, P Maheux, J Lu… - … medical research and …, 2011 - Taylor & Francis
Objective: To assess the safety and efficacy of saxagliptin (5 mg once-daily) in older patients
(≥65 years of age) with inadequately controlled type 2 diabetes. Research design and …
(≥65 years of age) with inadequately controlled type 2 diabetes. Research design and …
